4th Quarter - Termination
RICCHETTI INCORPORATED for AMGEN INC.
Client
Income
$60,000
Expenses
—
Terminated
Dec 31, 2024
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 16, 2025 | $60,000 | Replaced |
| 4th Quarter - Termination (this page) | Jan 21, 2025 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to drug pricing and access, Medicare and Medicaid reimbursement; Issues relating to the Medicaid drug rebate program proposed rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Pharmacy PHA
Issues related to pharmaceutical industry, generally; Drug pricing and access, and Medicare and Medicaid reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.